GENETICS OF BREAST CANCER AND HORMONE REPLACEMENT THERAPY
BACKGROUND The major known risk factors for female breast cancer are associated with prolongedexposure to increased levels of oestrogen. The predominant theory suggests that enhancedcell proliferation, induced either by endogenous or exogenous oestrogens, increasesthe number of cell divisions and th...
Main Authors: | Ksenija Geršak, Jasmina Živa Černe |
---|---|
Format: | Article |
Language: | English |
Published: |
Slovenian Medical Association
2008-12-01
|
Series: | Zdravniški Vestnik |
Online Access: | http://vestnik.szd.si/index.php/ZdravVest/article/view/854 |
Similar Items
-
THE USE OF HORMONE REPLACEMENT THERAPY IN SLOVENIAN WOMEN BEFORE THE FIRST DIAGNOSIS OF BREAST CANCER
by: Ksenija Geršak, et al.
Published: (2018-02-01) -
<it>KRAS </it>rs61764370 is associated with HER2-overexpressed and poorly-differentiated breast cancer in hormone replacement therapy users: a case control study
by: Cerne Jasmina-Ziva, et al.
Published: (2012-03-01) -
Breast cancer: estrogens as carcinogens
by: Jasmina-Živa Černe, et al.
Published: (2013-01-01) -
HORMONE REPLACEMENT THERAPY AND BREAST CANCER – NEWS ANDRECOMMENDATION
by: Marjetka Uršič Vrščaj, et al.
Published: (2008-12-01) -
Exploring the Relationship of Hormone Replacement Therapy and Breast Cancer
by: Wan-Chen Shen, et al.
Published: (2009)